InMed Pharmaceuticals's total assets for Q3 2024 were $13.36M, a decrease of -12.43% from the previous quarter. INM total liabilities were $2.25M for the fiscal quarter, a -9.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.